FDMT
4D Molecular Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$14.97
+1.84%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 52.36x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.03x
- Price / sales
- 8.99x
- Price / cash flow
- -5.30x
Enterprise value
- Enterprise value
- $504.9M
- EV / sales
- 5.49x
- EV / EBITDA
- -2.73x
- EV / EBIT
- -2.56x
- Market cap
- $827.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026